Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys

Abstract Mesenchymal stromal cells (MSC) are potential renal therapeutics. Clinically, results are mixed partly because MSC tropism to kidneys is minimal following infusion. Ultrasound augmentation of the renal microenvironment is becoming increasingly-important in renal MSC therapies. We demonstrat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Scott R. Burks, Ben A. Nguyen, Michele N. Bresler, Matthew E. Nagle, Saejeong J. Kim, Joseph A. Frank
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e17a4fdb4d774efe834c4097a6cba931
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e17a4fdb4d774efe834c4097a6cba931
record_format dspace
spelling oai:doaj.org-article:e17a4fdb4d774efe834c4097a6cba9312021-12-02T16:06:34ZAnti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys10.1038/s41598-017-08887-x2045-2322https://doaj.org/article/e17a4fdb4d774efe834c4097a6cba9312017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08887-xhttps://doaj.org/toc/2045-2322Abstract Mesenchymal stromal cells (MSC) are potential renal therapeutics. Clinically, results are mixed partly because MSC tropism to kidneys is minimal following infusion. Ultrasound augmentation of the renal microenvironment is becoming increasingly-important in renal MSC therapies. We demonstrated pulsed-focused-ultrasound (pFUS) increases enhanced homing permeability and retention of MSC in mouse kidneys. Here, we characterized the temporal proteomic response to pFUS in mouse kidneys and its association with MSC tropism. pFUS induced molecular cascades of initial increases in tumor necrosis factor-α (TNFα) and interleukin (IL)-1α, that activated nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) and cyclooxygenase-2 (COX2) pathways without cell death. This was followed by a 24–48 hour-long response of increased cell adhesion molecules (CAM), trophic and anti-inflammatory factors. Pretreating animals with anti-inflammatory drugs etanercept (TNFα inhibitor), anakinra (IL-1 receptor antagonist), prednisone (NFκB translocation inhibitor), or ibuprofen (COX inhibitor) suppressed molecular changes and inhibited renal MSC tropism. We further examined the role of COX2 using a COX2-knock-out mouse where pFUS was unable to increase MSC tropism. These results demonstrate that renal micro-environmental changes induce MSC tropism and could influence the therapeutic efficacy of MSC. Optimizing the microenvironment and understanding drug effects will enable improvements in MSC therapies for renal disease.Scott R. BurksBen A. NguyenMichele N. BreslerMatthew E. NagleSaejeong J. KimJoseph A. FrankNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Scott R. Burks
Ben A. Nguyen
Michele N. Bresler
Matthew E. Nagle
Saejeong J. Kim
Joseph A. Frank
Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
description Abstract Mesenchymal stromal cells (MSC) are potential renal therapeutics. Clinically, results are mixed partly because MSC tropism to kidneys is minimal following infusion. Ultrasound augmentation of the renal microenvironment is becoming increasingly-important in renal MSC therapies. We demonstrated pulsed-focused-ultrasound (pFUS) increases enhanced homing permeability and retention of MSC in mouse kidneys. Here, we characterized the temporal proteomic response to pFUS in mouse kidneys and its association with MSC tropism. pFUS induced molecular cascades of initial increases in tumor necrosis factor-α (TNFα) and interleukin (IL)-1α, that activated nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) and cyclooxygenase-2 (COX2) pathways without cell death. This was followed by a 24–48 hour-long response of increased cell adhesion molecules (CAM), trophic and anti-inflammatory factors. Pretreating animals with anti-inflammatory drugs etanercept (TNFα inhibitor), anakinra (IL-1 receptor antagonist), prednisone (NFκB translocation inhibitor), or ibuprofen (COX inhibitor) suppressed molecular changes and inhibited renal MSC tropism. We further examined the role of COX2 using a COX2-knock-out mouse where pFUS was unable to increase MSC tropism. These results demonstrate that renal micro-environmental changes induce MSC tropism and could influence the therapeutic efficacy of MSC. Optimizing the microenvironment and understanding drug effects will enable improvements in MSC therapies for renal disease.
format article
author Scott R. Burks
Ben A. Nguyen
Michele N. Bresler
Matthew E. Nagle
Saejeong J. Kim
Joseph A. Frank
author_facet Scott R. Burks
Ben A. Nguyen
Michele N. Bresler
Matthew E. Nagle
Saejeong J. Kim
Joseph A. Frank
author_sort Scott R. Burks
title Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
title_short Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
title_full Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
title_fullStr Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
title_full_unstemmed Anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
title_sort anti-inflammatory drugs suppress ultrasound-mediated mesenchymal stromal cell tropism to kidneys
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/e17a4fdb4d774efe834c4097a6cba931
work_keys_str_mv AT scottrburks antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
AT benanguyen antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
AT michelenbresler antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
AT matthewenagle antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
AT saejeongjkim antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
AT josephafrank antiinflammatorydrugssuppressultrasoundmediatedmesenchymalstromalcelltropismtokidneys
_version_ 1718384994701803520